• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

SHINE Technologies to Acquire Lantheus’ SPECT Imaging Business

by Fred Pennic 05/09/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– SHINE Technologies, a nuclear fusion company with an expanding platform of medical isotope products, today announced it has entered into a definitive agreement to acquire the SPECT (Single-Photon Emission Computed Tomography) business from Lantheus, a leading radiopharmaceutical-focused company. 

– The strategic acquisition includes the portion of Lantheus’ North Billerica, Massachusetts campus dedicated to the manufacturing of its SPECT products.

SHINE’s Expanding Isotope Production Capabilities

This acquisition complements SHINE’s significant investments in isotope production infrastructure. The company’s large-scale irradiation facility, “Chrysalis,” is poised to become the largest isotope production facility in the world. Once operational, Chrysalis will play a crucial role in the existing supply chain, ensuring a sustainable and reliable source of vital isotopes. These include Molybdenum-99 (Mo-99), the world’s most widely-used medical isotope, and Lutetium-177 (Lu-177), recognized as the most widely-used cancer-fighting isotope.

Further bolstering its production capacity, SHINE opened one of the largest facilities in the Western Hemisphere last year specifically dedicated to producing non-carrier-added lutetium-177. This facility currently has a production capacity of up to 100,000 doses of Lu-177 per year, with the potential to expand to 200,000 doses annually.

SHINE’s Broader Vision: From Medical Isotopes to Fusion Energy

Headquartered in Janesville, Wisconsin, SHINE is an industry leader in next-generation fusion technology, developing innovative solutions that emphasize safety, cost-efficiency, and environmental responsibility. The company has successfully commercialized fusion applications in neutron testing markets, including neutron radiography and radiation-effects testing.

Beyond its scaling medical isotope production for diagnosing heart disease and cancer, as well as for cancer therapy, SHINE is also pioneering nuclear waste recycling to enhance the sustainability of nuclear energy. The company’s long-term vision is to transform energy production through the commercialization of fusion energy, following a commercially driven path similar to successful deep-tech industries. This acquisition of Lantheus’ SPECT business is another strategic step in SHINE’s multi-faceted approach to leveraging fusion technology for widespread benefit.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Healthcare Mergers & Acquisitions

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Digital Health Funding Q3 2025: Choppy Undercurrents Beneath a Steady Surface

Featured Interview

ConcertAI VP Shares View on AI Hallucinations and the Fabricated Data Crisis in Scientific Publishing

Most-Read

Cleveland Clinic and Khosla Ventures Form Strategic Alliance to Accelerate Healthcare Innovation

Cleveland Clinic and Khosla Ventures Form Strategic Alliance to Accelerate Healthcare Innovation

Northwell Health Selects to Deploy Abridge’s Ambient AI Across 28 Hospitals

Northwell Health to Deploy Abridge’s Ambient AI Across 28 Hospitals

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Launches AI-Powered Meal Map to Transform Nutrition for Cardiometabolic Patients

From Overwhelmed to Optimized: How AI Agents Address Staffing Challenges and Burnout in Healthcare

From Overwhelmed to Optimized: How AI Agents Address Staffing Challenges and Burnout in Healthcare

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

KLAS Report: Epic's Native Ambient Speech Tool Reshapes Customer AI Strategies

KLAS Report: Epic’s Native Ambient Speech Tool Reshapes Customer AI Strategies

Epic Unveils MyChart Central and New APIs to Advance Interoperability at Open@Epic

Epic Outlines Roadmap for Next-Generation Data Sharing at Open@Epic

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |